`571-272-7822
`
`
`Paper No. 37
`
`Entered: July 5, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`FISHER & PAYKEL HEALTHCARE LIMITED,
`Petitioner,
`
`v.
`
`RESMED LIMITED,
`Patent Owner.
`____________
`
`Cases1
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`____________
`
`
`Before BARRY L. GROSSMAN, BEVERLY M. BUNTING, and
`JAMES J. MAYBERRY, Administrative Patent Judges.
`
`BUNTING, Administrative Patent Judge.
`
`
`
`
`ORDER
`Trial Hearing
`37 C.F.R. § 42.70
`
`
`
`
`1 This Order addresses issues that are the same in each case. Therefore, we
`exercise our discretion to issue one Decision to be filed in each case. The
`parties are not authorized to use this style heading for any subsequent
`papers.
`
`
`
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`
`
`Petitioner, Fisher & Paykel Healthcare Limited, and Patent Owner,
`ResMed Limited, requested and was granted oral argument in IPR2017-
`00632. Paper 19, 1. However, oral argument, originally scheduled for May
`1, 2018, was canceled in response to the U.S. Supreme Court’s decision in
`SAS Inst., Inc. v. Iancu, 2018 WL 1914661 (U.S. Apr. 24, 2018) and newly
`added challenges to this proceeding. See Paper 28, 1. As we indicated in
`our Order dated May 18, 2018, unless the parties request otherwise, oral
`hearing will be conducted on July 11, 20182 with respect to all challenges in
`this proceeding. Paper 31, 4.
`For IPR 2017-00272, as indicated in our Order dated May 18, 2018,
`unless the parties request otherwise, a supplemental oral hearing will be
`conducted on July 11, 2018. Paper 28, 4. This supplemental oral hearing is
`limited to the challenges added to this proceeding in response to the U.S.
`Supreme Court’s decision in SAS.
`Oral argument will commence at 9:00 AM ET on July 11, 2018.
`The hearing will be conducted at the Midwest Regional USPTO Office,
`300 River Place South, Suite 2900, Detroit, Michigan.3
`In IPR 2017-00632, each party will have forty-five (45) minutes to
`present its arguments, for a total of 90 minutes. Petitioner bears the ultimate
`burden of proof that the claims at issue in this review are unpatentable.
`Therefore, at oral hearing Petitioner will proceed first to present its case with
`
`
`2 Pursuant to a request from the panel, the parties conferred and agreed to
`this modification of the date set for oral argument in the Order. Paper 9, 7.
`This Order serves to amend Due Date 7 provided in the Scheduling Order
`for this proceedings. Id.
`3 See https://www.uspto.gov/about-us/uspto-locations/detroit-michigan for
`additional information.
`
`
`
`2
`
`
`
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`
`regard to all challenged claims and grounds on which basis we instituted
`trial in IPR2017-00632. Petitioner may reserve rebuttal time. Thereafter,
`Patent Owner will argue its opposition to Petitioner’s case. Petitioner may
`use any time Petitioner reserved to rebut Patent Owner’s opposition. Patent
`Owner may not reserve rebuttal time. No live testimony from any witness
`will be taken at the oral argument. Also, the parties are reminded that, at the
`oral argument, they “may rely upon evidence that has been previously
`submitted in the proceeding and may only present arguments relied upon in
`the papers previously submitted.” Office Patent Trial Practice Guide, 77
`Fed. Reg. 48,756, 48,768 (Aug. 14, 2012). “No new evidence or arguments
`may be presented at the oral argument.” Id.
`After a brief recess, a similar format will be used regarding the newly-
`added challenges at issue in IPR2017-00272 post-SAS with the noted
`exceptions. For the supplemental oral hearing in IPR2017-00272, each party
`will have twenty (20) minutes to present its arguments, for a total of 40
`minutes. Because this is a supplemental hearing, argument is limited to the
`challenges added to this proceeding in response to the U.S. Supreme Court’s
`decision in SAS.
`Both hearings will be open to the public for in-person attendance,
`which will be accommodated on a first-come, first-served basis. If the
`parties have any concern about disclosing confidential information, they are
`requested to contact the Board at least three days in advance of the hearing
`to discuss the matter.
`The Board will provide a court reporter for the hearings, and the
`reporter’s transcript will constitute the official record of each hearing. The
`hearing transcript will be entered in the record of each proceeding.
`
`
`
`3
`
`
`
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`
`
`Demonstrative exhibits must be served on opposing party three (3)
`business days prior to the hearing. The parties are directed to submit a copy
`of any demonstrative exhibits by email to Trials@uspto.gov at least three (3)
`business days prior to the hearing. The parties must file any objections to
`the demonstratives with the Board at least one (1) business days before the
`hearing. The objections should identify with particularity which
`demonstratives are subject to objection, and include a short (one sentence or
`less) statement of the reason for each objection. No argument or further
`explanation is permitted. Any objection to demonstrative exhibits that is not
`timely presented will be considered waived. Additionally, the Board expects
`that the parties will meet and confer in good faith to resolve any objections
`to demonstrative exhibits, but if such objections cannot be resolved, the
`parties may raise any objections during their allotted time in the hearing.
`The Board asks the parties to confine demonstrative exhibit objections to
`those identifying egregious violations that are prejudicial to the
`administration of justice. The parties may refer to CBS Interactive Inc. v.
`Helferich Patent Licensing, LLC, IPR2013-00033 (PTAB October 23, 2013)
`(Paper 118), and St. Jude Medical, Cardiology Div., Inc. v. The Board of
`Regents of the University of Michigan, IPR2013-00041 (PTAB Jan. 27,
`2014) (Paper 65) regarding the appropriate content of demonstrative
`exhibits.
`At least one member of the panel will be attending the hearings
`electronically from a remote location and will only have access to the
`courtesy copy of the demonstratives provided in advance, as referenced
`above, and will not be able to view the projection screen in the hearing
`room. Thus, if a demonstrative exhibit is not made available in advance or
`
`
`
`4
`
`
`
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`
`visible to the judge(s) presiding over the hearings remotely, that
`demonstrative exhibit will not be helpful. The parties are reminded that each
`presenter must identify clearly and specifically each demonstrative exhibit
`(e.g., by slide or screen number) referenced during the hearing to ensure the
`clarity and accuracy of the reporter’s transcript and for the benefit of the
`judge(s) presiding over the hearing remotely. A hard copy of the
`demonstratives, if used, may be provided to the court reporter at the hearing.
`The Board expects lead counsel for each party to be present in person
`at the oral hearings. Lead or backup counsel, however, may present the
`party’s argument. If either party anticipates that its lead counsel will not be
`attending the oral argument, the parties should request a joint telephone
`conference with the Board no later than two (2) business days prior to the
`oral hearing to discuss the matter.
`Specific requests for video equipment should be directed to
`Trials@uspto.gov at least three (3) days in advance of the hearing date. If
`the request is not received timely, the equipment may not be available on the
`day of the hearing. Questions regarding specific audio-visual equipment
`should be directed to the Board at (571) 272-9797.
`
`It is
`ORDERED that oral argument will commence at 9:00 AM ET on July
`11, 2018 at the Midwest Regional USPTO Office.
`
`
`
`
`
`5
`
`
`
`IPR2017-00272 (Patent 9,242,062 B2)
`IPR2017-00632 (Patent 8,944,061 B2)
`
`PETITIONER:
`
`Sheila N. Swaroop
`Brenton R. Babcock
`Benjamin J. Everton
`Joseph F. Jennings
`William O. Adams
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2sns@knobbe.com
`2brb@knobbe.com
`2bje@knobbe.com
`2jfj@knobbe.com
`2woa@knobbe.com
`
`
`For PATENT OWNER:
`
`Michael T. Hawkins
`Michael J. Kane
`Christopher C. Hoff
`Andrew Dommer
`Stephen R. Schaefer
`Geoffrey D. Biegler
`FISH & RICHARDSON P.C.
`hawkins@fr.com
`kane@fr.com
`hoff@fr.com
`dommer@fr.com
`schaefer@fr.com
`biegler@fr.com
`IPR36784-0053IP1@fr.com
`PTABInbound@fr.com
`
`Joseph A. Rhoa
`Paul Bowen
`NIXON & VANDERHYE P.C.
`jar@nixonvan.com
`ptb@nixonvan.com
`
`
`
`6
`
`